Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yui Pong Siu"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Chronic kidney disease (CKD) requires accurate prediction of renal replacement therapy (RRT) initiation risk. This study developed deep learning algorithms (DLAs) to predict RRT risk in CKD patients by incorporating medical histor
Externí odkaz:
https://doaj.org/article/941515df853f4b9d92ffb11e75a0bd83
Autor:
King Yee Ying, Ka Hang Tong, Cheuk Wan Yim, Woon Leung Ng, Chi Hung To, Yui Pong Siu, Chi Chiu Mok
Publikováno v:
Annals of the Rheumatic Diseases. 75:30-36
Objective To compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) for the initial therapy of lupus nephritis (LN). Study design This is an open randomised controlled parallel group study. Methods Adult patients with biopsy-confirm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d87bfb6419e270ea3b790db06d1c5cfb
https://doi.org/10.1136/annrheumdis-2014-206456
https://doi.org/10.1136/annrheumdis-2014-206456
Autor:
YUI-PONG SIU1, KAY-TAI LEUNG1, KA-HANG TONG, MATTHEW1 khmtong@netvigator.com, YUK-LUNG KWOK1, PIK-KEI WONG2, TZE-HOI KWAN1
Publikováno v:
Nephrology. Dec2005, Vol. 10 Issue 6, p619-622. 4p.
Autor:
Yui Pong Siu1, Matthew Kh Tong1 khmtong@netvuigator.com, Wai Lun Poon2, Wai Chuen Tsui2, Tze Hoi Kwan1
Publikováno v:
Nephrology. Feb2005, Vol. 10 Issue 1, p37-39. 3p.
Publikováno v:
Journal of nephrology. 21(1)
We report on the successful treatment of 5 consecutive adult patients with steroid-dependent or frequently relapsing minimal change disease (MCD), using a regimen of enteric-coated mycophenolate sodium (E-MPS) and prednisolone. E-MPS was used for ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6c0fc6c6e7a3cad7b43268d8cdde129
https://pubmed.ncbi.nlm.nih.gov/18264946
https://pubmed.ncbi.nlm.nih.gov/18264946
Publikováno v:
Medicine. 86(4)
We conducted the current study to compare the incidence and risk factors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis. We identified patients in whom lupus nephritis and non-lupus primary glomerulonephritis were diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d25842219d3b296c00be014d82234b
https://pubmed.ncbi.nlm.nih.gov/17632261
https://pubmed.ncbi.nlm.nih.gov/17632261
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 19(3)
This 6-month randomized double-blind placebo-controlled trial shows that risedronate is well tolerated and effective in improving lumbar spine BMD and reducing loss of BMD at the hips in patients receiving high-dose prednisolone.Bisphosphonates have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b55b62b23b18fc0f1b55388c90295e
https://pubmed.ncbi.nlm.nih.gov/18711408
https://pubmed.ncbi.nlm.nih.gov/18711408
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 20(12)
Objectives. The purpose of this study was to evaluatethe outcome of systemic lupus erythematosus (SLE)patients on continuous ambulatory peritoneal dialysis(CAPD).Methods. Eighteen SLE patients who had been under-going CAPD for at least 3 months in ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e35a4af8010047fc8e89e78c433e305
https://pubmed.ncbi.nlm.nih.gov/16384832
https://pubmed.ncbi.nlm.nih.gov/16384832
Publikováno v:
Kidney international. 68(2)
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study. Background Tacrolimus is a relatively new calcineurin inhibitor that has been increasingly used in transplant medicine. The objective of the curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28560e4ae0cbb2e4ea8476467b5bf76f
https://pubmed.ncbi.nlm.nih.gov/16014060
https://pubmed.ncbi.nlm.nih.gov/16014060
Autor:
Matthew Ka Hang, Tong, Kay Tai, Leung, Yui-Pong, Siu, Kit Fan, Lee, Hoi Kan, Lee, Chun Yun, Yung, Tze Hoi, Kwan, Tak Cheung, Au
Publikováno v:
Journal of nephrology. 18(2)
Intraperitoneal (IP) urokinase is a fibrinolytic agent that has been used in the adjunctive treatment of continuous ambulatory peritoneal dialysis (CAPD) and resistant and relapsing peritonitis. However, its efficacy and role in treating resistant CA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88908b14c5e4586bc4057a65b222769f
https://pubmed.ncbi.nlm.nih.gov/15931649
https://pubmed.ncbi.nlm.nih.gov/15931649